Rhythm Pharmaceuticals, Inc. (RYTM)

Rhythm Pharmaceuticals Revenue

In the year 2023, Rhythm Pharmaceuticals had annual revenue of $77.43M with 227.56% growth. Revenue in the quarter ending December 31, 2023 was $24.23M with 175.70% year-over-year growth.

• Revenue (ttm): $77.43M
• Revenue Growth: +227.56%
• P/S Ratio: 29.73
• Revenue / Employee: $342,602
• Employees: 226
• Market Cap: 2.30B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	77.43M	53.79M	227.56%
Dec 31, 2022	23.64M	20.48M	649.46%
Dec 31, 2021	3.15M	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.